Pfizer's Trading Volume Drops 28 Percent to $966 Million, Ranks 67th in Daily Volume

On April 2, 2025, Pfizer's trading volume reached $966 million, marking a 28.24% decrease from the previous day. The stock closed with a 0.65% increase, placing it at the 67th position in terms of trading volume for the day.

Pfizer's stock experienced a decline due to the uncertainty surrounding President Trump's proposed tariffs on pharmaceutical imports. The announcement led to a drop in after-hours trading, with Pfizer's stock falling slightly.

Pfizer's revenue from its COVID-19 medicine Paxlovid saw a significant increase, generating $5.7 billion in sales in 2024 compared to $1.2 billion in 2023. This substantial growth highlights the company's strong performance in the pharmaceutical sector.

In response to the proposed tariffs, Pfizer, along with other pharmaceutical companies, is taking measures to secure supply lines and fast-track shipments. This proactive approach aims to mitigate the potential impact of the tariffs on the global drug supply chain.